Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 3.580.877.7010.934.24

What is the latest Core EBITDA Margin ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Margin ratio of SAMRAT PHARMACHEM is 3.58 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar20253.58
Mar20240.87
Mar20237.70
Mar202210.93
Mar20214.24

How is Core EBITDA Margin of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Margin % Change
Mar2025 3.58
311.49
Mar2024 0.87
-88.70
Mar2023 7.7
-29.55
Mar2022 10.93
157.78
Mar2021 4.24 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Margin ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹78.5 Cr -1.2% -11.6% -34.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,068.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,847.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,985.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,826.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,418.0 Cr 1.5% 6.4% 4.8% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-1.2%

-11.6%

-34.6%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses